Supplemental folic acid in pregnancy and childhood cancer risk

Jan Helge Seglem Mortensen, Nina Øyen, Tatiana Fomina, Mads Melbye, Steinar Tretli, Stein Emil Vollset, Tone Bjørge*

*Corresponding author for this work
16 Citations (Scopus)

Abstract

Background:We investigated the association between supplemental folic acid in pregnancy and childhood cancer in a nation-wide study of 687 406 live births in Norway, 1999-2010, and 799 children diagnosed later with cancer.Methods:Adjusted hazard ratios (HRs) compared cancer risk in children by approximated periconceptional folic acid levels (folic acid tablets and multivitamins (0.6 mg), only folic acid (0.4 mg), only multivitamins (0.2 mg)) and cancer risk in unexposed.Results:Any folic acid levels were not associated with leukemia (e.g., high-level folic acid HR 1.25; 95% CI 0.89-1.76, P Trend 0.20), lymphoma (HR 0.96; 95% CI 0.42-2.21, P Trend 0.51), central nervous system tumours (HR 0.68; 95% CI 0.42-1.10, P Trend 0.32), neuroblastoma (HR 1.05; 95% CI 0.53-2.06, P Trend 0.85), Wilms' tumour (HR 1.16; 95% CI 0.52-2.58, P Trend 0.76), or soft-tissue tumours (HR 0.77; 95% CI 0.34-1.75, P Trend 0.90).Conclusions:Folic acid supplementation was not associated with risk of major childhood cancers.

Original languageEnglish
JournalBritish Journal of Cancer
Volume114
Pages (from-to)71-75
Number of pages5
ISSN0007-0920
DOIs
Publication statusPublished - 2016

Keywords

  • childhood cancer
  • cohort study
  • folic acid supplementation
  • pregnancy

Fingerprint

Dive into the research topics of 'Supplemental folic acid in pregnancy and childhood cancer risk'. Together they form a unique fingerprint.

Cite this